Skip to content
#diffusion models Open access

Multimodal Magnetic Resonance Imaging and Machine Learning Uncovers Distinct Progression Patterns in Friedreich Ataxia.

Sep 2026 · Movement Disorders · 0 citations · 35 references
Medicine

TL;DR

Longitudinal multimodal MRI shows distinct neurodegenerative progression patterns in FRDA that are not fully captured by conventional clinical measures, and provides a basis for investigating imaging-derived disease heterogeneity and its potential relevance to participant stratification in clinical trials.

Abstract

Background

Friedreich ataxia (FRDA) is a rare neurodegenerative disorder with heterogenous clinical progression, complicating prognosis and trial design. Neuroimaging offers objective biomarkers of disease progression, yet variability in progression patterns remains poorly understood.

Objective

The objective of this study is to identify distinct neurodegenerative progression patterns in FRDA using longitudinal multimodal magnetic resonance imaging (MRI) and to evaluate associations with clinical, demographic, and genetic factors.

Methods

Longitudinal structural and diffusion MRI data from 54 patients with FRDA and 57 controls were analyzed. Annualized progression rates of macrostructural (volumetric) and microstructural (diffusion) features across cerebellum, brainstem, and spinal cord regions were clustered using Gaussian Mixture Models. Following model selection, clusters were evaluated for biological plausibility of longitudinal imaging trajectories, bootstrap and subsampling reproducibility, and consistency of case-control composition. Associations with demographic, genetic, and clinical variables were examined, and Random Forest modeling assessed predictors of cluster membership.

Results

Four statistical clusters were identified, three of which represented robust, biologically interpretable progression patterns characterized by predominant microstructural degeneration, predominant macrostructural atrophy, and minimal measurable progression. The microstructure- and macrostructure-dominant patterns were enriched for FRDA participants, whereas the minimal-progression pattern contained more controls. GAA1 repeat length was the only variable consistently associated with cluster membership, with larger expansions observed in the microstructure-dominant pattern. Disease duration and clinical progression rates did not significantly differentiate progression patterns.

Conclusions

Longitudinal multimodal MRI shows distinct neurodegenerative progression patterns in FRDA that are not fully captured by conventional clinical measures. This data-driven framework provides a basis for investigating imaging-derived disease heterogeneity and its potential relevance to participant stratification in clinical trials. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Read PDF

Similar papers

Sep 2026

Imaging subtypes reveal distinct biological substrates and disability profiles in multiple sclerosis.

Multimodal MRI analysed with SuStaIn identified reproducible subtypes of multiple sclerosis with clinically meaningful differences in phenotype, age at onset, disability, and relapse-independent progression, while cognitive impairment was related to advancing SuStaIn stage within each subtype.

P. Preziosa, L. Storelli, F. Clarelli et al. · 0 citations
Review Open access 2026

Machine Learning for Multiple Sclerosis: A Systematic Review of Data and Methodologies

This systematic review consolidates recent advances in ML for MS diagnosis and monitoring and proposes a task-based taxonomy linking clinical objectives to methodological families, providing a comprehensive roadmap toward building robust, data-efficient, and trustworthy ML systems for clinical decision support in MS.

Marthe Elgawly, Beyza Nur Elaslan, Marco Cascio et al. · 0 citations
#diffusion models Open access Aug 2026

Lesion-Level Subtypes of White Matter Hyperintensity Evolution Beyond Spatial Location

Lesion composition may offer a more informative framework than global WMH burden for understanding cerebrovascular contributions to aging and neurodegeneration, with potential implications for risk stratification, clinical interpretation, and targeted interventions.

Raúl González-Gómez, Enzo Tagliazuchi, C. G. Campo et al. · 0 citations
Editorial Open access Aug 2026

Imaging Biomarkers in Parkinson's Disease and Movement Disorders: Emerging Insights from Multimodal Neuroimaging.

While these multimodal biomarkers offer unprecedented mechanistic insights into disease progression and therapeutic response, their ultimate value depends on successful clinical translation, it would be essential for the field to prioritize standardized acquisition protocols, automated post-processing pipelines, and ac...

E. Haacke, S. Buch, Naying He et al. · 0 citations
Review Open access Aug 2026

Multimodal MRI biomarkers and machine learning in neuromyelitis optica spectrum disorder: a review

Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing inflammatory demyelinating disease of the central nervous system that can result in substantial cumulative neurological disability. Magnetic resonance imaging (MRI) plays a central role in lesion detection, differential diagnosis, and longitudinal assessment...

Jiahui Zhang, Hao-You Xu, Min Zhao et al. · 0 citations
Open access Sep 2026

Data-driven subtypes of Alzheimer’s Disease: A multicohort study

These findings, replicated in four diverse and independent datasets, support imaging-based subtyping as a scalable and clinically translatable approach for capturing heterogeneity in AD pathophysiology and associated cognitive trajectories.

A. Metz, Cassandra Polizzi, R. Moqadam et al. · 0 citations

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.